Laparoscopic "DA VINCI" Robot Assisted Abdominal Wall Hernia Repair (ARTE)

August 1, 2013 updated by: Assistance Publique - Hôpitaux de Paris

Assistance Robotics for the Surgical Treatment of the Abdominal Wall Hernia

The aim of this study is to prove the superiority of the robotic assistance in laparoscopic repair of abdominal wall hernias .

In this monocentric randomized controlled trial, the use of the DA VINCI robot might reduce the post-operative pain of the patient resulting in a 40% reduction of morphine consumption.

Study Overview

Detailed Description

Laparoscopic Robot Assisted abdominal wall hernia repair : a prospective randomized trial:

The main judgement criterion is post operative pain reflected by morphine consumption during the first 48 hours. Secondary criteria are morbidity, quality of life, duration of surgery, conversion rate, complications, the the length of stay and hospital costs.

In this single centre study, inclusion criteria are age above 18, no previous repair of the hernia with a mesh and a diameter of the parietal defect of less than 10 cm. Contraindications are chronic use of pain drugs of level II or above and renal insufficiency (clearance <30ml/min).

The robotic repair was described in a previous paper of our group and will be compared to our classical laparoscopic repair technique, and in both cases with the use of the same prosthetic mesh.

A total of 70 patients to be included in an 18 months period was calculated to prove a 40% reduction in morphine consumption during the postoperative 48h (α=5% and β=10%).

The total duration of the study is 30 months (12 months of follow-up for each patient).

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Créteil, France, 94000
        • Groupe Hospitalier Chenevier-Mondor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • over 18 years
  • with indication of hernia repair
  • a collar with a diameter of less than 10cm
  • no antecedent of hernia treatment with poses plate
  • agreeing coelioscopy
  • agreeing to participate the clinical study, having sign an informed consent
  • agreeing a regular monitor

Exclusion Criteria:

  • taking analgesic tier 2 or 3
  • against indication to anesthetics or coelioscopy
  • creatinine clearance less than 30 ml/min
  • pregnant woman and protected persons
  • no affiliation to social security
  • unable to understand the information form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
robot-assisted coelioscopy
Patients with abdominal wall hernia will be treated by robot-assisted coelioscopy for the poses of abdominal plate
Other Names:
  • Laparoscopic DA VINCI Robot Assisted abdominal coelioscopy
Active Comparator: 2
conventional coelioscopy
Patients with abdominal wall hernia will be treated by conventional coelioscopy for the poses of abdominal plate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Evaluate the reduction in morphine consumption
Time Frame: during the postoperative 48h
during the postoperative 48h

Secondary Outcome Measures

Outcome Measure
Time Frame
Pain patient (ENS, total consumption of morphine)
Time Frame: during the hospitalization, to 10 days,1 month, 6 months and 12 months of surgery
during the hospitalization, to 10 days,1 month, 6 months and 12 months of surgery
quality of life (questionary SF-36)
Time Frame: 1 month, 6 month and 12 month of surgery
1 month, 6 month and 12 month of surgery
length of stay in hospital, percentage return home to 24 hours of surgery
Time Frame: to 24 hours of surgery
to 24 hours of surgery
morbidity
Time Frame: during the study
during the study
resumption of work
Time Frame: after surgery
after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claude Tayar, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2007

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

May 22, 2009

First Submitted That Met QC Criteria

May 22, 2009

First Posted (Estimate)

May 25, 2009

Study Record Updates

Last Update Posted (Estimate)

August 2, 2013

Last Update Submitted That Met QC Criteria

August 1, 2013

Last Verified

July 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Wall Hernia

Clinical Trials on Laparoscopic DA VINCI Robot Assisted coelioscopy

Subscribe